• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠纤溶酶原激活物基因功能缺失的生理后果。

Physiological consequences of loss of plasminogen activator gene function in mice.

作者信息

Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord J J, Collen D, Mulligan R C

机构信息

Whitehead Institute of Biomedical Research, Cambridge, Massachusetts 02142.

出版信息

Nature. 1994 Mar 31;368(6470):419-24. doi: 10.1038/368419a0.

DOI:10.1038/368419a0
PMID:8133887
Abstract

Indirect evidence suggests a crucial role for the fibrinolytic system and its physiological triggers, tissue-type (t-PA) and urokinase-type (u-PA) plasminogen activator, in many proteolytic processes. Inactivation of the t-PA gene impairs clot lysis and inactivation of the u-PA gene results in occasional fibrin deposition. Mice with combined t-PA and u-PA deficiency suffer extensive spontaneous fibrin deposition, with its associated effects on growth, fertility and survival.

摘要

间接证据表明,纤维蛋白溶解系统及其生理触发因子,即组织型(t-PA)和尿激酶型(u-PA)纤溶酶原激活剂,在许多蛋白水解过程中起关键作用。t-PA基因失活会损害血凝块溶解,u-PA基因失活会导致偶尔的纤维蛋白沉积。同时缺乏t-PA和u-PA的小鼠会出现广泛的自发性纤维蛋白沉积,并对生长、生育能力和生存产生相关影响。

相似文献

1
Physiological consequences of loss of plasminogen activator gene function in mice.小鼠纤溶酶原激活物基因功能缺失的生理后果。
Nature. 1994 Mar 31;368(6470):419-24. doi: 10.1038/368419a0.
2
Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.纤溶基因靶向失活的小鼠内皮瘤细胞的纤溶酶原依赖性和非依赖性蛋白水解活性
Thromb Haemost. 1997 Feb;77(2):362-7.
3
Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.纤溶酶原激活物和纤溶酶原激活物抑制剂-1基因功能联合失活在小鼠中的生物学效应
Thromb Haemost. 1995 Oct;74(4):1126-31.
4
The role of the fibrinolytic system in corneal angiogenesis.纤溶系统在角膜血管生成中的作用。
Angiogenesis. 2003;6(4):311-6. doi: 10.1023/B:AGEN.0000029414.24060.fe.
5
Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.纤溶系统各组分在内皮损伤诱导的血栓形成与清除中的不同作用。
Thromb Haemost. 1999 Apr;81(4):601-4.
6
The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.组织型纤溶酶原激活物缺失及相关纤维蛋白(原)沉积对巨噬细胞在腹膜炎症中定位的影响。
Thromb Haemost. 2006 Apr;95(4):659-67.
7
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
8
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.急性肺损伤中的凝血、纤维蛋白溶解及纤维蛋白沉积
Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB.
9
Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.组织型纤溶酶原激活剂(t-pA)和尿激酶型纤溶酶原激活剂(u-PA)对饮食诱导肥胖小鼠模型脂肪组织发育的影响
Thromb Haemost. 2002 Feb;87(2):306-10.
10
Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.口腔外科中的止血——口腔纤维蛋白溶解对出血可能的发病机制影响。口腔内止血平衡的实验与临床研究,尤其涉及获得性和先天性凝血系统缺陷患者。
Dan Med Bull. 1991 Dec;38(6):427-43.

引用本文的文献

1
Hormonal Regulation of Urokinase- and Tissue-Type Plasminogen Activator in Mouse Sertoli Cells.小鼠支持细胞中尿激酶型和组织型纤溶酶原激活剂的激素调节
Mol Reprod Dev. 2025 Jan;92(1):e70012. doi: 10.1002/mrd.70012.
2
Regulation of macrophage fibrinolysis during venous thrombus resolution.调控巨噬细胞纤溶在静脉血栓溶解中的作用。
Thromb Res. 2024 Nov;243:109149. doi: 10.1016/j.thromres.2024.109149. Epub 2024 Sep 14.
3
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.
靶向纤维蛋白溶解抑制治疗静脉血栓栓塞症:一种新兴治疗方法概述。
Circulation. 2024 Sep 10;150(11):884-898. doi: 10.1161/CIRCULATIONAHA.124.069728. Epub 2024 Sep 9.
4
Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.新型泛癌抗 uPAR 荧光纳米抗体的构建及鉴定:用于影像引导手术的工具。
Adv Sci (Weinh). 2024 Aug;11(30):e2400700. doi: 10.1002/advs.202400700. Epub 2024 Jun 6.
5
Fibrinolytic-deficiencies predispose hosts to septicemia from a catheter-associated UTI.纤溶缺陷使宿主易患导管相关性尿路感染引起的败血症。
Nat Commun. 2024 Mar 27;15(1):2704. doi: 10.1038/s41467-024-46974-6.
6
Neutrophil extracellular traps and DNases orchestrate formation of peritoneal adhesions.中性粒细胞胞外陷阱和脱氧核糖核酸酶共同调控腹膜粘连的形成。
iScience. 2023 Oct 27;26(12):108289. doi: 10.1016/j.isci.2023.108289. eCollection 2023 Dec 15.
7
The role of fibrinolysis in vascular diseases in UK biobank.纤维蛋白溶解在英国生物银行血管疾病中的作用。
J Thromb Thrombolysis. 2023 Nov;56(4):635-638. doi: 10.1007/s11239-023-02876-w. Epub 2023 Aug 11.
8
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States.纤溶抑制和低纤溶不是同义词:区分低纤溶状态的临床意义。
Semin Thromb Hemost. 2023 Jul;49(5):433-443. doi: 10.1055/s-0042-1758057. Epub 2022 Nov 1.
9
Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis.可溶性尿激酶型纤溶酶原激活物受体水平与原发性硬化性胆管炎患者的纤维化严重程度相关。
J Clin Med. 2022 Apr 28;11(9):2479. doi: 10.3390/jcm11092479.
10
tPA-NMDAR Signaling Blockade Reduces the Incidence of Intracerebral Aneurysms.tPA-NMDAR 信号阻断可降低颅内动脉瘤的发生率。
Transl Stroke Res. 2022 Dec;13(6):1005-1016. doi: 10.1007/s12975-022-01004-9. Epub 2022 Mar 21.